BioSystem Development, a Madison, Win.-based life science analytics company, recently completed a $978,000 round of funding.
Investors include existing backers and and new business angels from Wisconsin, Illinois, North Carolina, California and New York.
The capital will enable the company to expand its manufacturing infrastructure and to launch new products into the biopharmaceutical development market.
Established in 2002, BioSystem Development creates, manufactures and markets tools and products designed to meet the needs of pharmaceutical development. The company’s AssayMAP platform, based on disposable micro-chromatography cartridges and automation, enables high throughput solutions for bioprocess development, biomarkers and general life science research.
Commenting on the round, founder and CEO Scott Fulton said: “This funding provides us the means to respond to growing market interest and launch several new disruptive AssayMAP products”.